Applied DNA Submits Validation Package To New York State Department Of Health To Expand Linea Mpox Virus 1.0 Assay To Mpox Clade I And Clade II; Validation Studies Confirmed The Assay Can Detect Mpox Clade I And Clade Ib In Addition To Clade II
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences has submitted a validation package to the New York State Department of Health to expand the use of its Linea Mpox Virus 1.0 Assay to detect additional mpox clades. The assay has shown 100% homology to mpox clade I and clade Ib, which is significant given the WHO's recent public health emergency declaration. Approval from NYSDOH is pending.
August 23, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences has submitted a validation package to expand its Linea Mpox Virus 1.0 Assay to detect additional mpox clades. The assay has shown 100% homology to mpox clade I and clade Ib. Approval from NYSDOH is pending.
The submission of the validation package to NYSDOH for expanding the assay's use to additional mpox clades is a positive development for Applied DNA Sciences. Successful validation studies and the potential approval could enhance the company's product offerings and market position, especially given the WHO's recent public health emergency declaration. This news is likely to have a positive short-term impact on APDN's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100